CIK 0001490978 · Large accelerated filer
Schrodinger, Inc.
Sign in to watch- Ticker
- SDGR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 954284541
- Phone
- 503-299-1150
- Business address
- 1540 BROADWAY, 24TH FLOOR, NEW YORK, NY, 10036
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,781,663
- in 3 filings, $2.8M under 10b5-1 plans
Net −$2,781,663. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-02 | Abel Robert Lorne See Remarks | Grant or award | +17,130 | 36,515 | ||
| 2026-03-02 | Abel Robert Lorne See Remarks | Grant or award | +20,682 | 57,197 | ||
| 2026-03-02 | Abel Robert Lorne See Remarks | Grant or award · Stock Option (right to buy) | +34,250 | 34,250 | ||
| 2026-03-02 | Herman Jenny CAO | Grant or award | +9,590 | 36,187 | ||
| 2026-03-02 | Herman Jenny CAO | Grant or award · Stock Option (right to buy) | +8,220 | 8,220 | ||
| 2026-03-02 | Tran Yvonne EVP, CLO & CPO | Grant or award | +17,130 | 39,989 | ||
| 2026-03-02 | Tran Yvonne EVP, CLO & CPO | Grant or award | +13,788 | 53,777 | ||
| 2026-03-02 | Tran Yvonne EVP, CLO & CPO | Grant or award · Stock Option (right to buy) | +34,250 | 34,250 | ||
| 2026-03-02 | Lorton Kenneth Patrick EVP, CTO & COO, Software | Grant or award | +17,130 | 69,781 | ||
| 2026-03-02 | Lorton Kenneth Patrick EVP, CTO & COO, Software | Grant or award | +20,682 | 90,463 | ||
| 2026-03-02 | Lorton Kenneth Patrick EVP, CTO & COO, Software | Grant or award · Stock Option (right to buy) | +34,250 | 34,250 | ||
| 2026-03-02 | Farid Ramy President & CEO | Grant or award 10b5-1 | +56,250 | 278,182 | ||
| 2026-03-02 | Farid Ramy President & CEO | Grant or award 10b5-1 | +13,604 | 291,786 | ||
| 2026-03-02 | Farid Ramy President & CEO | Grant or award 10b5-1 | +48,259 | 340,045 | ||
| 2026-03-02 | Farid Ramy President & CEO | Sale 10b5-1 | −5,560 | $11.90 | $66K | 334,485 |
| 2026-03-02 | Farid Ramy President & CEO | Grant or award · Stock Option (right to buy) 10b5-1 | +112,500 | 112,500 | ||
| 2026-03-02 | Akinsanya Karen See Remarks | Grant or award 10b5-1 | +24,250 | 39,875 | ||
| 2026-03-02 | Akinsanya Karen See Remarks | Grant or award 10b5-1 | +6,077 | 45,952 | ||
| 2026-03-02 | Akinsanya Karen See Remarks | Grant or award 10b5-1 | +27,576 | 73,528 | ||
| 2026-03-02 | Akinsanya Karen See Remarks | Sale 10b5-1 | −2,206 | $11.99 | $26K | 71,322 |
Page 4 of 11 · 214 trades